Home/Filings/4/0001600620-24-000124
4//SEC Filing

Leversage Jill 4

Accession 0001600620-24-000124

CIK 0001600620other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 4:36 PM ET

Size

6.7 KB

Accession

0001600620-24-000124

Insider Transaction Report

Form 4
Period: 2024-11-21
Transactions
  • Award

    Director Stock Option (right to buy)

    2024-11-21+18,64118,641 total
    Exercise: $8.24Exp: 2034-11-21Common Shares (18,641 underlying)
  • Award

    Common Shares

    2024-11-21+12,13525,053 total
Footnotes (2)
  • [F1]Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
  • [F2]The options shall vest one year from date of grant.

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1
  • filerCIK 0001837374

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 4:36 PM ET
Size
6.7 KB